Diabetes, Vol 47, Issue 12 1836-1840, Copyright © 1998 by American Diabetes Association
Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase
J Zhou, QK Huynh, RT Hoffman, ED Crook, MC Daniels, EA Gulve and DA McClain
Department of Medicine, University of Mississippi Medical Center, Jackson 39216, USA.
Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limiting
enzyme in hexosamine biosynthesis, an important pathway for cellular
glucose sensing. Human GFA has two potential sites for phosphorylation by
cAMP-dependent protein kinase A (PKA). To test whether GFA activity is
regulated by cAMP-dependent phosphorylation, rat aortic smooth muscle cells
were treated in vivo with cAMP-elevating agents, 10 micromol/l forskolin, 1
mmol/l 8-Br-cAMP, or 3-isobutyl-1-methylxanthine. All treatments resulted
in rapid and significant increases (2- to 2.4-fold) in GFA activity assayed
in cytosolic extracts. Maximal effects of forskolin were observed at 10
micromol/l and 60 min. Preincubation of cells with cycloheximide did not
abolish the effect of forskolin. Incubation of cytosolic extracts at 37
degrees C for 10 min in a buffer without phosphatase inhibitors led to a
79% decrease of GFA activity. This loss of activity was inhibited by the
addition of phosphatase inhibitors (5 mmol/l sodium orthovanadate, 50
mmol/l sodium fluoride, or 5 mmol/l EDTA, but not 100 nmol/l okadaic acid),
suggesting that GFA undergoes rapid dephosphorylation by endogenous
phosphatases. Purified GFA is phosphorylated in vitro by purified PKA,
resulting in a 1.7-fold increase in GFA activity. Treatment of GFA with
purified protein kinase C had no effect. We conclude that GFA activity may
be modulated by cAMP-dependent phosphorylation.